Synergistic anticancer therapeutic effect of sorafenib and microRNA-21 inhibitor in Hepatocellular carcinoma

被引：0
|
作者：
Kim, J. Y. [1 ,2 ]
Lee, J. Y. [1 ,2 ]
Lee, R. J. [1 ]
Kim, M. H. [1 ,2 ]
Hwang, S. H. [1 ]
Song, G. W. [1 ]
Lee, S. G. [1 ]
Tak, E. Y. [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Ulsan, South Korea
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P142
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 50 条
  • [21] MicroRNA-21 as a diagnostic marker for hepatocellular carcinoma: A systematic review and meta-analysis
    Qu, Juan
    Yang, Jizhi
    Chen, Ming
    Cui, Lihong
    Wang, Tianxi
    Gao, Wei
    Tian, Jingjing
    Wei, Rongna
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2019, 35 (05) : 1466 - 1471
  • [22] MicroRNA-21 is overexpressed in renal cell carcinoma
    Lv, Lu
    Huang, Fengxian
    Mao, Haiping
    Li, Ming
    Li, Xiaoyan
    Yang, Man
    Yu, Xueqing
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2013, 28 (02): : 201 - 207
  • [23] Sorafenib Decreases Extrahepatic Collaterals in Hepatocellular Carcinoma: Implication of the Synergistic Effect of Sorafenib and Transcatheter Chemoembolization
    Tsai, I-Chen
    Yeh, Hong-Zen
    Tsai, Wei-Lin
    Tsai, Sheng-Heng
    Hwang, Jen-I
    CURRENT MEDICAL IMAGING REVIEWS, 2010, 6 (03) : 191 - 193
  • [24] Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
    Pelizzaro, Filippo
    Cardin, Romilda
    Sartori, Anna
    Imondi, Angela
    Penzo, Barbara
    Aliberti, Camillo
    Ponzoni, Alberto
    Vitale, Alessandro
    Cillo, Umberto
    Farinati, Fabio
    BIOMEDICINES, 2021, 9 (08)
  • [25] MicroRNA-21 A novel therapeutic target in human cancer
    Pan, Xuan
    Wang, Zhao-Xia
    Wang, Rui
    CANCER BIOLOGY & THERAPY, 2010, 10 (12) : 1224 - 1232
  • [26] Inhibition of microRNA-21 as a Therapeutic Strategy for Kidney Fibrosis
    Chau, N.
    Xin, C.
    Grafals, M.
    Tran, P.
    Castano, A. P.
    Linn, G.
    Ren, S.
    Li, J.
    Kersjes, K.
    Chang, A.
    Bhat, B.
    Hartner, J.
    Orkin, S.
    Portilla, D.
    MacKenna, D. A.
    Duffield, J. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 28 - 28
  • [27] Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway
    Li, Xuguang
    Chen, Weirun
    Liu, Kaihang
    Zhang, Sheng
    Yang, Ru
    Liu, Kairui
    Li, Dateng
    Huang, Youxing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 8081 - 8091
  • [28] CIRCULATING MICRORNA-21 AND HIF-1ALPHA IN CHRONIC LIVER DISEASES AND HEPATOCELLULAR CARCINOMA
    Pelizzaro, F.
    Cardin, R.
    Russo, F. P.
    Penzo, B.
    Pinto, E.
    Kitenge, M. P.
    Bertellini, F.
    Palano, G.
    Farinati, F.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S149 - S149
  • [29] Genetic or pharmacologic inhibition of microRNA-21 does not prevent liver fibrosis or hepatocellular carcinoma in mice
    Caviglia, J. Matias
    Jang, Myoung Kuk
    Gwak, Geum-Youn
    Mederacke, Ingmar
    Mu, Xueru
    Dapito, Dianne H.
    Schwabe, Robert F.
    HEPATOLOGY, 2014, 60 : 569A - 570A
  • [30] Effect of sofosbuvir and ribavirin on therapeutic efficacy of sorafenib in the treatment of hepatocellular carcinoma
    Rana, A.
    ANNALS OF ONCOLOGY, 2017, 28 : 58 - 58
12345